Establishment and validation of an immune infiltration predictive model for ovarian cancer.

Song, Zhenxia; Zhang, Jingwen; Sun, Yue; Jiang, Zhongmin; Liu, Xiaoning

Song, Zhenxia; Zhang, Jingwen; Sun, Yue; Jiang, Zhongmin; Liu, Xiaoning.

Afiliação

Song Z; Department of Obstetrics, Qingdao women and childeren's hospital, #6 Tongfu Road, Shibei District, Qingdao, Shandong, 266000, P. R. China.
Zhang J; Department of Obstetrics, Qingdao women and childeren's hospital, #6 Tongfu Road, Shibei District, Qingdao, Shandong, 266000, P. R. China.
Sun Y; Department of Obstetrics, Qingdao women and childeren's hospital, #6 Tongfu Road, Shibei District, Qingdao, Shandong, 266000, P. R. China.
Jiang Z; Department of Pathology, Tian Jin Fifth's Central Hospital, #41 Zhejiang Road, Binhai District, Tianjin, 300450, P. R. China.
Liu X; Department of Obstetrics, Qingdao women and childeren's hospital, #6 Tongfu Road, Shibei District, Qingdao, Shandong, 266000, P. R. China. evenalive@126.com.

BMC Med Genomics ; 16(1): 227, 2023 09 28.

Article em En | MEDLINE | ID: mdl-37759229

Assuntos

Linfócitos T CD8-Positivos; Neoplasias Ovarianas; Humanos; Feminino; Neoplasias Ovarianas/genética; Mutação; Células Matadoras Naturais; Macrófagos; Microambiente Tumoral

Palavras-chave

IPM; Immune infiltration; Ovarian cancer; TP53 mutation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Linfócitos T CD8-Positivos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google